Cargando…
Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1
BACKGROUND: The treatment of chronic myeloid leukemia (CML) is facing the dilemma of tyrosine kinase inhibitors (TKIs) resistance and disease recurrence. The dysfunctional DNA damage repair mechanism plays an essential role not only in the initiation and progression of hematological malignancies but...
Autores principales: | Zeng, Fanting, Peng, Yuhang, Qin, Yuefeng, Wang, Jianming, Jiang, Guoyun, Feng, Wenli, Yuan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793686/ https://www.ncbi.nlm.nih.gov/pubmed/36575478 http://dx.doi.org/10.1186/s12964-022-01021-z |
Ejemplares similares
-
circCRKL, a circRNA derived from CRKL, regulates BCR-ABL via sponging miR-877-5p to promote chronic myeloid leukemia cell proliferation
por: Wang, Jianming, et al.
Publicado: (2022) -
The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator
por: Jungmichel, Stephanie, et al.
Publicado: (2012) -
The HINT1 tumor suppressor regulates both γ-H2AX and ATM in response to DNA damage
por: Li, Haiyang, et al.
Publicado: (2008) -
MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance
por: Salguero, Israel, et al.
Publicado: (2019) -
MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
por: Watanabe, Sugiko, et al.
Publicado: (2018)